Figure 2

Time-to-Event analysis comparing the derived subgroups for the different biomarkers. Probability of CVD analyzed using Kaplan–Meier survival analysis with comparisons among the levels of AER (a; p value by Log rank = 0.52), urinary podocin mRNA (b; p value by Log rank < 0.0001) and urinary nephrin mRNA (c; p value by Log rank < 0.0001) using log-rank test.